The market for face rejuvenation is anticipated to develop as more products are introduced and approved for use. For instance, the Renuvion Dermal Handpiece was approved by the U.S. FDA in May 2022, but only for patients with fitzpatrick skin types, for the treatment of moderate to severe wrinkles and rhytides. Rising technological advancement approvals are anticipated to fuel market expansion throughout the forecast years. As an illustration, Alma, one of the world's leading providers of energy-based medical and aesthetic solutions, introduced the Alma PrimeXTM device for skin tightening in April 2021. The market's major companies are concentrating on forming subsidiaries to increase their geographic reach. For instance, InMode Ltd., a global provider of cutting-edge, radiofrequency minimally and non-invasive medical technology, concluded the foundation of two new subsidiaries in the Asia Pacific region, InMode India and InMode Australia, in October 2019. The Ministry of Health in the United Arab Emirates and Indonesia's Badan Pengawas Obat dan Makanan approved Daewoong Pharmaceutical, a South Korean pharmaceutical business, in December 2019 for their botulinum toxin product, Nabota.
Coherent Market Insights projects that the global Face Rejuvenation Market is anticipated to reach US$ 24,616.7 million in 2022 and grow at a CAGR of 7.7% over the following five years (2022-2030).
Key Players in the Facial Rejuvenation Industry:
1. Merz Pharma
The company was founded in 1908 and has its main office in Frankfurt, Germany. The business is involved in the study, creation, and distribution of goods related to cosmetic medicine and neurologically induced movement problems. Partnership for needleless treatment of overactive bladder to be launched by Merz and Israeli start-up Vensica in August 2021.
2. Anika Therapeutic
The firm was founded in 1983 and has its main office in Massachusetts, United States. Anika Therapeutics, Inc. creates, produces, and sells therapeutic goods for tissue defence, healing, and repair. The first operations using the revolutionary RevoMotion Reverse Shoulder Arthroplasty (RSA) System were carried out in the United States, the business stated in February 2023. At the American Society for Surgery of the Hand (ASSH) 2021 annual meeting in San Francisco, California, the WristMotion® Total Wrist Arthroplasty (TWA) System was introduced, according to a corporate announcement in Oct 2021.
3. Lumenis
The business was established in 1991 and has its main office in Israel. Medical equipment is distributed by Lumenis Inc. The business sells surgical laser systems and related items for urology and genitourinary procedures. The pioneer in energy-based medical technologies for applications in vision and aesthetics is Lumenis.
4. Galderma
The firm was founded in 1981 and has its main office in Switzerland. The business specialises on skin care items and dermatological procedures. Galderma paid an undisclosed sum in November 2021 to acquire California-based Alastin, a company that specialises in specialised skincare products. Relabotulinum toxin A considerably decreased the severity of frown lines and was well tolerated, according to positive results from two Phase III trials, which Galderma disclosed in June 2022.
5. Revance Therapeutics
The firm was founded in 1999 and has its main office in Nashville, Tennessee, United States. With cutting-edge medicinal and aesthetic products that improve patient and physician experiences, Revance is a biotechnology firm that is establishing a new benchmark in healthcare. The first and only peptide-formulated neuromodulator with long-lasting effects, DAXXIFYTM (DaxibotulinumtoxinA-lanm) for injection received FDA approval from Revance in sep 2022.
6. Cynosure,
The firm was founded in 1991 and has its main office in Massachusetts, United States. With regard to leg veins, hair care products, scar modification, port-wine skin tags, facial varicose veins, sagging skin, tattoos, and pigmented lesions, Cynosure Inc. develops and manufactures lasers.
7. Bausch Health Companies Inc.
The firm was founded in 1959 and has its main office in Laval, Canada. It creates, produces, and sells pharmaceuticals as well as name-brand generic medications, primarily for neurology, gastrointestinal, ocular, and skin conditions. Drugs are found and distributed by Bausch Health Companies Inc. Bausch Health announced plans to pursue a Solta Medical Initial Public Offering in August 2021.
*Definition: A cosmetic procedure called facial rejuvenation seeks to give the human face a more youthful appearance. Both surgical and non-surgical techniques are available for face rejuvenation. Procedures might vary in their invasiveness and depth of therapy.
